PUBLISHER: TechNavio | PRODUCT CODE: 1516162
PUBLISHER: TechNavio | PRODUCT CODE: 1516162
The 3D printing medical devices market is forecasted to grow by USD 7079.6 mn during 2023-2028, accelerating at a CAGR of 25.2% during the forecast period. The report on the 3D printing medical devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increased demand for personalized or customized medical devices, increasing adoption of 3D printing technology by medical professionals, and rising cost efficiency and enhanced productivity.
Technavio's 3D printing medical devices market is segmented as below:
Market Scope | |
---|---|
Base Year | 2024 |
End Year | 2028 |
Series Year | 2024-2028 |
Growth Momentum | Accelerate |
YOY 2024 | 19.78% |
CAGR | 25.2% |
Incremental Value | $7079.6mn |
By Application
By End-user
By Geographical Landscape
This study identifies the rising focus on the research for the use of 3D printing process to manufacture living organs and cell structures as one of the prime reasons driving the 3D printing medical devices market growth during the next few years. Also, rise in adoption of computer-aided design/computer-aided manufacturing (CAD/CAM) technology and desktop printers and rise in strategic collaborati will lead to sizable demand in the market.
The report on the 3D printing medical devices market covers the following areas:
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading 3D printing medical devices market vendors that include 3D Systems Corp., Anatomics Pty Ltd., Autodesk Inc., Biomerics LLC, Boston Scientific Corp., Desktop Metal Inc., EOS GmbH, Exail Technologies, Formlabs Inc., General Electric Co., INTAMSYS TECHNOLOGY CO. LTD., MATERIALISE NV, Mecuris GmbH, Medtronic Plc, Organovo Holdings Inc., Qualtech Consulting Corp., Renishaw Plc, Schultheiss GmbH, SLM Solutions Group AG, and Stratasys Ltd.. Also, the 3D printing medical devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Exhibits: